GREAT WEST LIFE ASSURANCE CO /CAN/ – Regeneron Pharmaceuticals, Inc. Transaction History
GREAT WEST LIFE ASSURANCE CO /CAN/ portfolio value:
$116.41M
portfolio value
GREAT WEST LIFE ASSURANCE CO /CAN/ quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.23% | -7.46K shares | 11.91M | $688.87 | 169.18K |
| Q2 2022 | share | Increase | +2.54% | 4.37K shares | -22.30M | $591.13 | 176.65K |
| Q1 2022 | share | Decrease | -0.94% | -1.63K shares | 17.24M | $698.42 | 172.27K |
| Q4 2021 | share | Increase | +10.47% | 16.48K shares | 13.73M | $642.51 | 173.91K |
| Q3 2021 | share | Increase | +3.05% | 4.65K shares | 10.52M | $605.18 | 157.43K |
| Q2 2021 | share | Decrease | -13.65% | -24.15K shares | 2.03M | $558.54 | 152.77K |
| Q1 2021 | share | Decrease | -6.46% | -12.22K shares | -7.89M | $473.14 | 176.93K |
| Q4 2020 | share | Increase | +27.47% | 40.75K shares | 9.94M | $483.11 | 189.15K |
| Q3 2020 | share | Increase | +14.04% | 18.27K shares | 477K | $559.78 | 148.39K |
| Q2 2020 | share | Increase | +102.85% | 65.97K shares | 49.20M | $623.65 | 130.12K |
| Q1 2020 | share | Decrease | -20.47% | -16.50K shares | 1.48M | $488.29 | 64.14K |
| Q4 2019 | share | Increase | +4.64% | 3.57K shares | 8.64M | $375.48 | 80.65K |
| Q3 2019 | share | Decrease | -8.58% | -7.23K shares | -4.95M | $277.4 | 77.07K |
| Q2 2019 | share | Increase | +0.46% | 388 shares | -8.00M | $313 | 84.31K |
| Q1 2019 | share | Increase | +27.22% | 17.95K shares | 10.57M | $410.62 | 83.92K |
| Q4 2018 | share | Increase | +34.35% | 16.86K shares | 3.93M | $373.5 | 65.96K |
| Q3 2018 | share | Decrease | -13.34% | -7.55K shares | 306K | $404.04 | 49.1K |
| Q2 2018 | share | Increase | +1.66% | 924 shares | 331K | $344.99 | 56.65K |
| Q1 2018 | share | Decrease | -21.69% | -15.43K shares | -7.51M | $344.36 | 55.73K |
| Q4 2017 | share | Increase | +6.97% | 4.63K shares | -2.31M | $375.96 | 71.17K |
| Q3 2017 | share | Increase | +20.96% | 11.52K shares | 2.05M | $447.12 | 66.53K |
| Q2 2017 | share | Decrease | -0.24% | -134 shares | 5.64M | $491.14 | 55.00K |
| Q1 2017 | share | Increase | +0.84% | 458 shares | 1.20M | $387.51 | 55.14K |
| Q4 2016 | share | Decrease | -1.54% | -854 shares | -2.17M | $367.09 | 54.68K |
| Q3 2016 | share | Increase | +2.60% | 1.41K shares | 3.44M | $402.02 | 55.53K |
| Q2 2016 | share | Increase | +31.67% | 13.02K shares | 4.06M | $349.23 | 54.12K |
| Q1 2016 | share | Decrease | -16.96% | -8.39K shares | -12.08M | $360.44 | 41.10K |